OSSIO
Bone becomes bone, not hardware
Boston, MA, US
OSSIO is a medical device company developing bio-integrative fixation technology for orthopedic surgery, where its implants provide stable fixation and are then fully replaced by the patient's own bone.
How We Help
Problem Statement
To eliminate the complications and need for secondary removal surgeries associated with traditional permanent metal orthopedic implants.
Core Technology
orthopedic fixation with bone regeneration technology
Key Differentiators
Proprietary bio-integrative material is stronger than cortical bone.; Implants are fully replaced by the patient's natural bone over time, leaving no permanent hardware behind.; Utilizes existing reimbursement codes and surgical techniques for easier adoption.
Clinical Focus
Orthopedic surgery
Company Info
- Business Model
- B2B
- Total Funding
- 101,100,000
- Website
- ossio.io
Categories
Technologies
Clinical & IP
Clinical Validation
FDA 510(k) cleared (bone pins, screws, nails, hammertoe). 96% fusion rate at 2 years. 100% patient satisfaction. Multi-center European trial completed. 92% fusion at 1-year. Zero adverse biological response.
MedStartr Index Score
?What do you think of OSSIO?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.